glp-1 revolution Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment weight gain The GLP-1 revolution: Measuring what
Description
Monthly growth rates were 83.9% for OZEMPIC, 119.2% for WEGOVY , 84.8% for RYBELSUS, 12.9% for ADLYXIN, 78.8% for TRULICITY, and 254.3% for MOUNJARO
Common side effects include gastrointestinal symptoms (nausea, vomiting, diarrhoea), which may lead to dehydration and electrolyte imbalances more rapidly in older adults
Bibcode:2017Natur.546..312S
2024;7(8):e2427258
